Skip to content

Facilitating Treatment Entry and Family Planning in Substance-using Neonatal Intensive Care Unit (NICU) Mothers

Facilitating Treatment Entry and Family Planning in Substance-using NICU Mothers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03165565
Enrollment
64
Registered
2017-05-24
Start date
2017-07-05
Completion date
2020-01-03
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

The purpose of this pilot study is to assess whether the hospital-based, adaptive behavioral intervention strategy promotes treatment entry and reduces risk of additional substance-exposed pregnancies (SEPs), as well as HIV and Hepatitis C Virus (HCV) risks among substance-using NICU mothers. Additionally, to assess whether the intervention increases use of professional obstetrical/gynecological resources for contraception to reduce substance-exposed pregnancies (SEPs).

Interventions

BEHAVIORALMotivational Interviewing (MI) and Acceptance and Commitment Therapy (ACT)

Participants will receive Motivational Interviewing (MI) and Acceptance and Commitment Therapy (ACT).

BEHAVIORALConventional Care

Conventional care from the hospital for NICU mothers who test positive for drug use, which includes visits and resources from hospital social workers.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have an infant in the NICU at Children's Memorial Hermann Hospital (CMHH) * have a positive urine drug screen at delivery or have an infant with a positive urine or meconium drug screen or self-reported drug use to a healthcare provider or had a documented positive drug screen during pregnancy * have access to a telephone.

Exclusion criteria

* currently attending substance abuse treatment * severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol * inability to read, write, speak English or Spanish * inability or unwillingness to provide signed consent for participation; (5) inability or unwillingness to meet study requirements.

Design outcomes

Primary

MeasureTime frameDescription
Treatment Entry8 weeksNumber of participants having at least one treatment session at a licensed substance use facility or with a licensed counselor
Substance Exposed Pregnancy (SEP) risk as as assessed by a modified Time-Line Follow Back-SEP (TLFB-SEP)2 monthsSubstance Exposed Pregnancy (SEP) risk as as assessed by a modified Time-Line Follow Back-SEP (TLFB-SEP)
HIV and HCV risk as assessed by Behavioral Risk Assessment for Infectious Disease (BRAID)2 monthsHIV and HCV risk as assessed by Behavioral Risk Assessment for Infectious Disease (BRAID)

Secondary

MeasureTime frameDescription
Number of participants whose infant had routine follow-up pediatric appointments6 monthsMedical records will be used, with participant consent, to assess the number of participants whose infant had routine follow-up pediatric appointments.
Number of participants whose infant had acute care visits6 monthsMedical records will be used, with participant consent, to assess the number of participants whose infant had acute care visits.
Number of participants whose infant had emergency department visits6 monthsMedical records will be used, with participant consent, to assess the number of participants whose infant had emergency department visits.
Depression as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)2 monthsDepression as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)
Number of participants who lost custody of the infant6 monthsMedical records will be used, with participant consent, and additionally the research team will collaborate with the NICU social worker and the assigned child protective services (CPS) caseworker, with participant consent, to obtain information about the number of participants who lost custody of the infant.
Number of participants for which any additional abuse or neglect complaints were filed after baseline6 monthsMedical records will be used, with participant consent, and additionally the research team will collaborate with the NICU social worker and the assigned child protective services (CPS) caseworker, with participant consent, to obtain information about the number of participants for which any additional abuse or neglect complaints were filed after baseline.
Drug use2 monthsNumber of participant who test positive for drug use as assessed by urine drug screen
Number of participants whose infant was re-hospitalized6 monthsMedical records will be used, with participant consent, to assess the number of participants whose infant was re-hospitalized.
Current position regarding motivation for change as assessed by the University of Rhode Island Change Assessment (URICA)2 monthsCurrent position regarding motivation for change as assessed by the University of Rhode Island Change Assessment (URICA)
Psychological flexibility as assessed by the Acceptance and Action Questionnaire-Substance Abuse (AAQ-SA)2 monthsThis self-report measure of psychological flexibility will assess a participant's willingness to have undesirable thoughts and feelings related to drug use while still pursuing self-identified goals. This version of the AAQ was specifically developed for substance-abusing populations.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026